Skip to main content

Conservative Management of Vesicovaginal Fistula

Conservative management with prolonged Foley catheter drainage is the least invasive first-line approach for appropriately selected vesicovaginal fistulae (VVFs). It is most effective for small (<5 mm), fresh, simple, non-irradiated fistulae identified early after iatrogenic injury — and only a minority of VVFs are suitable.[1][2][3]

For endoscopy-guided approaches once conservative management fails or the fistula is too large for it, see Endoscopic VVF Management. For the broader clinical evaluation and decision algorithm, see the vesicovaginal fistula clinical page.

Rationale​

Continuous bladder drainage decompresses the reservoir and eliminates the hydrostatic pressure gradient driving urine through the fistula tract. The fistula edges remain in apposition, allowing spontaneous epithelialization and closure. The underlying assumption — that the bladder heals better at rest — is empirical; robust supporting evidence is limited.[4]

Patient Selection​

Conservative catheter management suits only a minority of VVF cases.[1] Ideal candidates:

  • Small fistulae — generally <5 mm; some series accept up to ~1 cm.[5][3]
  • Fresh / early fistulae — identified within days to weeks of the inciting event (surgery, delivery), before the tract epithelializes.
  • Simple fistulae — no surrounding fibrosis, radiation changes, infection, or malignancy.
  • Non-irradiated tissue — prior radiotherapy is a major risk factor for failure of both conservative and surgical management.[6]
  • Iatrogenic etiology — post-hysterectomy or post-cesarean fistulae have better tissue quality than obstetric fistulae from prolonged obstructed labor.

Technique and Protocol​

Catheter​

  • 14–18 Fr transurethral Foley with the balloon inflated, on dependent gravity drainage.
  • The catheter must remain patent and unobstructed at all times — kinking, blockage, or inadvertent removal compromises healing.
  • A suprapubic catheter is an alternative or adjunct when urethral catheterization is difficult or urethral trauma from prolonged transurethral drainage is a concern.

Duration​

  • Typical range 2–12 weeks; most protocols use 4–8 weeks of continuous drainage.[5][7][8]
  • For obstetric VVFs, early continuous drainage within 4–6 weeks postpartum can produce spontaneous closure.[1]
  • One series used 12 weeks before proceeding to surgery, with 8/99 (8.1%) achieving spontaneous closure during the drainage period.[8]
  • If the fistula has not closed at 2 months, surgery should be considered.[5]

Assessment of closure​

  • After the planned drainage period, perform a dye test — retrograde bladder fill with methylene blue or indigo carmine.
  • If positive (persistent leakage), extending catheterization an additional 7 days results in subsequent closure in approximately 55.7%.[9]
  • Cystoscopy may be used to directly visualize the fistula site and confirm closure.

Adjunctive Measures​

AdjunctRationale
Anticholinergic medication (oxybutynin, tolterodine)Suppresses detrusor overactivity / bladder spasms that generate pressure across the fistula. Standard practice in most protocols.
AntibioticsTreat active UTI. Routine prophylactic antibiotics are not recommended in catheterized patients per IDSA, because of resistance concerns.[10]
Vaginal estrogenIn postmenopausal patients, topical estrogen may improve tissue quality and promote healing.
Nutritional optimizationAdequate protein intake; correct anemia.
Avoid irritantsNo vaginal douching, intercourse, or tampon use during the treatment period.

Success Rates​

SettingFistula sizeDrainage durationSuccess
Post-benign gynecologic surgery (Bodner-Adler meta-analysis)[2]VariableVariable92.9% (95% CI 79.5–99.9)
Obstetric VVF[2][3]<2 cm4–6 wk postpartumSpontaneous closure possible; exact rate uncertain
Tertiary referral (12-wk protocol)[8]Variable12 wk8.1% (8/99)
Small bladder-genital fistulae[5]<0.5 cmUp to 2 mo100% (3/3)
Post-hysterectomy / cesarean (larger 0.7–3.1 cm)[7]0.7–3.1 cmMedian 8 wk0% (all failed, required surgery)
Extended catheterization after positive post-repair dye test[9]VariableAdditional 7 d55.7% (29/52)

The Bodner-Adler 92.9% figure reflects significant selection bias — only the most favorable fistulae (small, fresh, simple) were managed conservatively. In unselected populations or larger fistulae, conservative management routinely fails. In one 24-patient series with mean fistula size 2.4 cm, a median 8 weeks of Foley drainage failed in all patients.[7]

When to Abandon Conservative Management​

Switch to surgical repair when:

  • No improvement after 6–8 weeks of continuous drainage.
  • Fistula >1–2 cm in diameter.
  • Tract epithelialization is visible on cystoscopy.
  • Fistula associated with radiation, malignancy, or significant fibrosis.
  • Active infection or foreign body (e.g., retained suture) at the fistula site.
  • Prior failed conservative management.

Prolonged unsuccessful conservative management should not delay definitive surgical repair — longer delay to surgery is an independent predictor of surgical failure.[6]

Postoperative Catheter Drainage (After Surgical Repair)​

Catheter drainage also plays a critical role after surgical VVF repair. Traditional practice has been 14 days, but a large multicenter RCT showed 7-day catheterization is non-inferior to 14-day after repair of simple fistulae — no increased risk of repair breakdown, urinary retention, or residual incontinence.[4] Most surgeons still maintain drainage 2–3 weeks for complex repairs.[3][1]

See Also​

References​

1. Okada Y, Matsushita T, Hasegawa T, et al. Surgical interventions for treating vesicovaginal fistula in women. Cochrane Database Syst Rev. 2026;1:CD015413. doi:10.1002/14651858.CD015413

2. Bodner-Adler B, Hanzal E, Pablik E, Koelbl H, Bodner K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: a systematic review and meta-analysis. PLoS One. 2017;12(2):e0171554. doi:10.1371/journal.pone.0171554

3. Wall LL. Obstetric vesicovaginal fistula as an international public-health problem. Lancet. 2006;368(9542):1201–1209. doi:10.1016/S0140-6736(06)69476-2

4. Barone MA, Widmer M, Arrowsmith S, et al. Breakdown of simple female genital fistula repair after 7-day vs 14-day postoperative bladder catheterisation: a randomised, controlled, open-label, non-inferiority trial. Lancet. 2015;386(9988):56–62. doi:10.1016/S0140-6736(14)62337-0

5. He Z, Cui L, Wang J, Gong F, Jia G. Conservative treatment of patients with bladder genital tract fistula: three case reports. Medicine. 2020;99(31):e21430. doi:10.1097/MD.0000000000021430

6. Zhang C, Saussine C, Tricard T. Urogenital fistulas: surgical management, outcomes, and prognostic factors: a 14-year monocentric experience. Int Urogynecol J. 2026. doi:10.1007/s00192-026-06580-0

7. Tozzi R, Spagnol G, Marchetti M, et al. Vaginal-laparoscopic repair (VLR) of primary and persistent vesicovaginal fistula: description of a new technique and surgical outcomes. J Clin Med. 2023;12(5):1760. doi:10.3390/jcm12051760

8. Mohr S, Brandner S, Mueller MD, Dreher EF, Kuhn A. Sexual function after vaginal and abdominal fistula repair. Am J Obstet Gynecol. 2014;211(1):74.e1–6. doi:10.1016/j.ajog.2014.02.011

9. Chang OH, Ganesh P, Wilkinson JP, Pope RJ. Extended bladder catheterization for women with positive dye tests after obstetric vesicovaginal fistula repair surgery. Int J Gynaecol Obstet. 2020;149(1):61–65. doi:10.1002/ijgo.13088

10. Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 195: Prevention of infection after gynecologic procedures. Obstet Gynecol. 2018;131(6):e172–e189. doi:10.1097/AOG.0000000000002670